FindTrial
Sign In

peri-operative blood management in hemophilic arthroplasty

peri-operative blood management in hemophilic arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021917
Enrollment
Unknown
Registered
2019-03-16
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemophilia arthropathy

Interventions

Case series:None

Sponsors

Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
23 Years to 48 Years

Inclusion criteria

Inclusion criteria: adult patient with hemophilia A and end-stage hemophilic arthropathy, scheduled for elective total joint replacement. aged 20 - 50 years old.

Exclusion criteria

Exclusion criteria: patient with serve hemophilia or high titer inhibitor.

Design outcomes

Primary

MeasureTime frame
total blood loss;hemoglobin change;—

Secondary

MeasureTime frame
coagulation factor comsumption;—

Countries

China

Contacts

Public ContactLi Yuhui

Guangzhou University of Traditional Chinese Medicine First Affiliated Hospital

liliuyuhui@126.com+86 13710890071

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026